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Objective The objective of this study was to compare the performance of the OSIRIS video-assisted reading
system for disk diffusion susceptibility testing with conventional manual reading.
Methods Prospectively collected clinical isolates (n = 119) and isolates with well-characterised resistant
mechanisms, including extended-spectrum (ESBL) or inhibitor-resistant TEM (IRT) If-lactamases
producing Enterobacteriaceae (80), methicillin-resistant Staphylococcus aureus (MRSA) (16) and vancomycin-
resistant enterococci (14) were studied using the National Committee for Clinical Laboratory Standards
disk-diffusion technique. The OSIRIS reading (inhibition zone in mm) was compared with manual reading
(reference value).
Results Essential agreement (<:::3 mm discrepancy with manual reading) was 91.6% in routine isolates and
94.8% in those with well-characterised resistant mechanisms, respectively. Overall agreement for
susceptibility testing interpretation was slightly higher in the former (95.5%) than in the latter (93.2%) group.
The presence of ESBL enzymes enhanced variations of measurements due to synergy among amoxicillin-
clavulanate and cephalosporins, as a consequence ofcloser disk placement. The poor growth characteristic of
enterococci affected the video reading; on the other hand, there was a high performance with MRSA
isolates. Combining all interpretative results, 4.1% minor, 1.0% major and 2.8% very major errors were
observed.
Conclusion The OSIRIS system is a useful tool for the reading and interpretation of inhibition zone sizes in
disk diffusion susceptibility testing.
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INTRODUCTION
Traditional disk diffusion in agar media for antimicrobial sus-
ceptibility testing is simple and inexpensive but can be a time-
consuming method for routine study due to inhibition zone size
measuring. Alternative methods include broth and agar dilu-
tion, antimicrobial gradient and automated instrument systems
[1]. Most of these automatic devices use microdilution panels,
which usually give a turbidimetric or nephelometric reading.
Recently, image-processing devices have been introduced in
these systems [2], a technology that has been previously applied
to disk diffusion reading [3-5]. We evaluated the OSIRIS
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system (Bio-Rad, Marnes la Coquette, France), an image
analysis-based method designed for the automatic determina-
tion of the inhibition zone diameters of disk diffusion. The
OSIRIS system uses an algorithm ofradial analysis ofthe profile
representing the pattern of bacterial growth on agar plates
around a paper disk containing an antibiotic. This system allows,
with the software and a video camera, the digitisation and
analysis ofimages. The OSIRIS system also allows profiles to be
clinically categorised as susceptible, intermediate or resistant to
the antibiotic tested, according to the National Committee for
Clinical Laboratory Standards (NCCLS) [6] or Comite de
l'Antibiogramme de la Societe Franl'aise de Microbiologie
(SFM) standards [7]. In the present study we compared the
OSIRIS automated inhibition zone readings with those pro-
vided by conventional disk diffusion manual readings. Perfor-
mance was assayed using the same agar plates in both readings. A
clinical collection of organisms commonly found in clinical
laboratories and a collection with known resistant mechanisms
were used for this purpose.
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MATERIALS AND METHODS
Bacterial isolates
We studied 119 clinical isolates prospectively collected at the
Hospital Ramon y Cajal. The number of isolates tested per
species was as follows: 63 Enterobacteriaceae (one Citrobacter
freundii, two Enterobacter aerogenes, two Ent. aglomerans, one Ent.
asburiae, five Ent. cloacae, 26 Escherichia coli, two Klebsiella oxytoca,
seven Kleb. pneumoniae, one Kluyvera spp., one Morganella
morganii, eight Proteus mirabilis, one Providencia stuartii, four
Salmonella spp., and one Yersinia enterocolitica); 33 Staphylococcus
spp. (13 Staph. aureus, 14 Staph. epidermidis, two Staph. hominis,
one Staph.lugdunensis, two Staph. simulans, and one Staph. warnert);
eight Enterococcus spp. (five Ent. faecalis, two Ent. durans, and one
Ent. casselifiavus); and 15 non-fermentative Gram-negative rods
(one Acinetobacter baumannii, one A. lwoffi, one Chromobacterium
violaceum, one Empedobacter brevis, one Flavobacterium spp., six
Pseudomonas aeruginosa, and four Stenotrophomonas maltophilia).
In addition, 110 clinical isolates with known resistance mechan-
isms were also included: 80 Enterobacteriaceae, 74 extended-
spectrum (ESBL) and six inhibitor-resistant-TEM (IRT)
p-lactamase-producing isolates (36 Kleb. pneumoniae, 29 Esch.
coli, six Ent. cloacae, one Ent. aerogenes, one Ent. gergoviae, one
Citrobacter freundii, two Kleb. oxytoca, and four Salm. enteritidis);
16 methicillin-resistant Staph. aureus (MRSA); and 14 vanco-
mycin-resistant enterococci (VRE) (nine Ent. faecalis and five
Ent. faecium).
Susceptibility testing
Disk diffusion was performed as outlined in the NCCLS
performance standards [6], assuring a confluent growth. For
each isolate, 12-14 different antimicrobial disks were assayed.
Disks were distributed on Mueller-Hinton 120-mm2 plates
according to a predefined standard scheme that depended on
the species tested. Antimicrobials tested in each group ofisolates
were as follows: ampicillin, amoxicillin-clavulanate, ticarcillin,
cefazolin, cefuroxime, cefoxitin, cefotaxime, ceftazidime, imi-
penem, gentamicin, tobramycin, amikacin, nalidixic acid and
ciprofloxacin for Enterobacteriaceae; ticarcillin, piperacillin,
cefotaxime, ceftazidime, aztreonam, cefoxitin, imipenem,
meropenem, gentamicin, amikacin, ciprofloxacin, tobramycin,
trimethoprim-sulfamethoxazole, and tetracycline for non-
fermentative Gram-negative rods (NFGNRs); cefazolin, gen-
tamicin, tobramycin, amikacin, ciprofloxacin, vancomycin,
teicoplanin, erythromycin, tetracycline, pristinamycin, oxacil-
lin, and clindamycin for staphylococci; and ampicillin,
penicillin, vancomycin, teicoplanin, gentamicin (500 J-lg), strep-
tomycin (500 J-lg), cefotaxime, imipenem, trimethoprim-sulfa-
methoxazole, clindamycin, pristinamycin, erythromycin, and
tetracycline for enterococci. Bio-Rad laboratories provided
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antibiotic disks. Interpretative categories (susceptible, inter-
mediate and resistant) were calculated for each zone measure-
ment for each organism-antimicrobial agent combination
tested following the NCCLS guidelines [6]. In their absence,
the available SFM recommendations were used [7]. This
resulted in no important interpretive errors.
Reference inhibition zone values
Manual reading of inhibition zones with a ruler was considered
as reference value.
Interpretation of results
When the inhibition zone value in the OSIRIS system was in
the susceptible category and in the resistant category with the
reference method, the result was classified as 'very major error'.
Conversely, 'major error' was used when the result in the
OSIRIS system was in the resistant category and susceptible
in the reference method, and 'minor errors' when the result
with one method was in the susceptible or resistant category and
in the intermediate category with the other method. Essential
agreement was defined when the difference between the inhi-
bition zone value in the reference method and the OSIRIS
system was minor or equal to 3 mm. Acceptable levels of
error were performed according to the American Society for
Microbiology (ASM)[ 8], NCCLS [9], and Food and Drug
Administration (FDA) [10].
RESULTS
Table 1 shows the performance of the OSIRIS system for both
clinical isolates and those with well-characterised resistant
mechanisms. Figure 1 shows the distribution of isolates within
the indicated discrepancy in the inhibition zone reading
between the OSIRIS system and manual reading. The OSIRIS
system tended to read lower inhibition zones when compared
with manual readings. This was observed both in clinical isolates
and in the collection with well-characterised resistant mechan-
isms. Considering all clinical isolates, essential agreement
(<:::3 mm discrepancy with manual reading) was 91.6%, ranging
from 90.0% for NFGNRs to 94.2% for Staphylococcus spp. In
isolates with a well-characterised resistance mechanism, the
global essential agreement was higher (94.8%) than that
obtained with clinical isolates. The highest essential agreement
was observed with ESBL- and IRT-producing isolates (95.8%)
and with MRSA isolates (95.8%). On the other hand, the lowest
essential agreement was observed with VRE (87.4%). This
value was even lower than that obtained for clinical isolates
of enterococci (92.3%).
Overall agreement for susceptibility testing interpretation
was slightly higher in routine clinical isolates (95.5%) than in
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Table 1 Performance of the OSIRIS system for routine clinical isolates and isolates with well-characterised mechanisms of resistance
Essential
Organisms (number of No. of antimicrobials Organism-antimicrobial agreement (%) Errors (%)
isolates tested) tested combinations tested (-<:3mm) m M VM
Routine clinical isolates
Enterobactenaceae(63) 14 882 90.7 2.6 1.0 4.7
NFGNRs (15) 14 210 90.0 6.2 1.8 2.4
Staphylococcus spp. (33) 12 396 94.2 1.7 0.3 4.4
Enterococcus spp. (8) 13 104 92.3 4.8 1.7 2.5
TOTAL 1592 91.6 3.0 0.9 3.8
Isolates with well-characterised
resistance mechanism
ESBL- and IRT-producing isolates (80) 14 1120 95.8 5.8 0.5 1.4
MRSA (16) 12 192 95.8 3.1 0.0 1.6
VRE (14) 13 182 87.4 3.3 8.4 6.8
TOTAL 1494 94.8 5.2 1.1 2.3
m, minor errors; M, major errors; VM, very major errors; NFGNRs, nonfermentative gram-negative rods; ESBL, extended-spectrum-Il-Iactamase; IRT, inhibitor
resistantTEM; MRSA, methicillin-resistant S. aureus; VRE, vancomycin-resistant enterococci.
those obtained in isolates with well-characterised resistant
mechanisms (93.2%). Discrepancies in routine clinical isolates
were mainly due to amoxicillin-clavulanate (0.4% when con-
sidering the total number of susceptibility tests and 8.3% when
considering the total number of discrepancies), cefoxitin (0.4%
and 8.3%, respectively) and tobramycin (0.3% and 6.9%, respec-
tively) Discrepancies in isolates with well-characterised resistant
mechanisms were mainly concentrated in cefotaxime (1.1 % and
16.7%), cefuroxime (1.1% and 15.7%) and amoxicillin-clavu-
lanate (0.5% and 7.8%) susceptibility testing (data not shown).
In both groups, these discrepancies were mainly observed
with Enterobacteriaceae. Tables 2 and 3 illustrate these varia-
tions for different If-Iactams in clinical Enterobacteriaceae
isolates and ESBL- or IRT-producing Enterobacteriaceae
isolates, respectively.
Combining all interpretative resnlts for clinical isolates













mechanism, 4.1% minor errors, 1.0% major errors and 2.8%
very major errors were observed. The corresponding values for
routine clinical isolates were 3.0% minor errors, 0.9% major
errors, and 3.8% very major errors (Table 1). In this group, the
most important percentage of errors was obtained with
NFGNRs. Despite the small number of the isolates tested
(n = 15), discrepancies appeared to be randomly distributed
among these isolates and different antibiotics. For all isolates
with a well-characterised resistance mechanism, 5.2% minor
errors, 1.1% major errors and 2.3% very major errors were
observed (Table 1). The highest percentage of errors was
observed for VRE. In MRSA isolates, a total of 1.6% very
major errors were observed and all of them were due to
ciprofloxacin. Moreover, 3.1% minor errors were detected in
MRSA isolates, 84% being due to amikacin. Interestingly, no
errors were observed with oxacillin and MRSA isolates (data
not shown in tables). A low percentage of very major errors
o Clinical isolates
Known resistance mechanisms
<3 -3 -2 -1 o
mm
2 3 >3
Figure 1 Distribution of isolates within the indicated discrepancy in the inhibition zone reading with the OSIRIS system and manual reading.
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Table 2 Performance of the OSIRIS system and Il-Iactan antibiotics with Enterobacteriaceae clinical isolates
Number of isolates displaying the
following mm difference within
indicated manual reference mm Number and percentage of errors
Antimicrobial agent <-3 -3 -2 -1.0,1 2 3 >3 Minor Major Very major
Ampicillin 1 2 5 50 2 2 1 4/63 6% 1/19 5% 0/41 0%
Amoxicillin-davulanate 4 1 7 38 3 3 7 4/63 6% 1/46 2% 1/11 9%
Ticarcillin 1 0 4 47 3 5 3 1/63 2% 1/28 4% 0/33 0%
Cefazolin 1 1 5 53 0 0 3 1/63 2% 0/48 0% 1/14 7%
Cefuroxime 1 3 10 44 0 0 5 2/63 3% 0/54 0% 0/7 0%
Cefoxitin 2 1 9 41 1 1 8 4/63 6% 1/52 2% 0/10 0%
Cefotaxime 3 3 3 51 0 0 3 3/63 5% 0/58 0% 0/0 0%
Ceftazidime 1 2 5 46 5 1 3 1/63 2% 1/61 2% 0/2 0%
Imipenem 0 1 2 42 5 5 8 0/63 0% 0/63 0% 0/0 0%
TOTAL 14 14 50 412 19 17 41 20/567 3.5% 5/427 1.2% 2/130 1.5%
Table 3 Performance of the OSIRIS system and Il-Iactan antibiotics with Enterobacteriaceae producing ESBL and IRTenzymes and Il-Iactam antibiotics
Number of isolates displaying the
following mm difference within
indicated manual reference mm Number and percentage of errors
Antimicrobial agent <-3 -3 -2 -1.0,1 2 3 >3 Minor Major Very major
Ampicillin 0 0 0 78 0 2 0 0/80 0% 0/0 0% 0/80 0%
Amoxicillin-davulanate 0 0 12 63 1 2 2 7/80 8.7% 0/37 0% 1/29 3.4%
Ticarcillin 0 0 0 80 0 0 0 0/80 0% 0/2 0% 0/78 0%
Cefazolin 2 3 11 51 2 10 1 6/80 7.5% 0/9 0% 0/64 0%
Cefuroxime 0 5 14 54 0 4 3 16/80 20% 0/28 0% 0/43 0%
Cefoxitin 3 2 14 58 1 1 1 5/80 6.2% 1/68 1.5% 0/10 0%
Cefotaxime 3 5 22 47 2 0 1 16/80 20% 0/26 0% 0/7 0%
Ceftazidime 0 1 16 56 1 2 4 5/80 6.2% 0/47 0% 1/26 3.8%
Imipenem 2 2 7 61 4 2 2 0/80 0% 0/80 0% 0/0 0%
TOTAL 10 18 96 548 11 23 14 55/720 7.6% 1/297 3.4% 2/337 0.6%
(1.4%) were found in Enterobacteriaceae with ESBL or IRT
enzymes (Table 3). These very major errors were mainly due to
amoxicillin-clavulanate, ceftazidime (Table 3) and gentamicin
(data not shown).
DISCUSSION
Computer-assisted image-processing technology is increasingly
applied to susceptibility testing devices with both conventional
disk diffusion agar plates [3-5,11] and microdilution panels [2].
The former technique is one of the simplest, most reliable and
least costly susceptibility testing methods [1], but is generally
considered tedious and time-consuming due to the need to
measure inhibition zone sizes. The introduction of an auto-
mated method of measuring zone sizes overcomes this limita-
tion, allowing rapid reading and interpretative categorisation. In
the present study, we have evaluated the OSIRIS system, a
newly introduced video reader system. Similar to other auto-
mated zone readers [3,5,11], after image digitisation, the com-
plete antibiogram image appears on the computer screen. If
necessary, zone sizes can easily be adjusted when synergies,
antagonism, or microcolonies in the inhibition zones are pre-
sent. With the exception of evident disturbances of synergy or
antagonism in the inhibition zone shapes, the analysis in our
study was performed without modifYing the OSIRIS reading.
In our study, a total of 3086 organism-antimicrobial agent
combinations were analyzed: 1592 were from routine clinical
isolates and 1494 from those organisms with a well-charac-
terised resistant mechanism (Table 1). In general, the OSIRIS
system tended to read lower inhibition zones when compared
with manual readings (Figure 1). This tendency is contrary to
that noted with other automated zone readers [11] and affected
clinical categorisation and interpretative errors, particularly
with major and minor errors. Independent of this particular
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issue, the global essential agreement (93.1 %) with both groups
was similar to that obtained in a preliminary evaluation of the
OSIRIS system performed by Haddad-Prost et al. [12]. This
global essential agreement met the criteria established to define
the accuracy ofsusceptibility testing methods [13]; however, the
percentage of errors exceeded that commonly recommended
for antimicrobial susceptibility testing systems [8-10] (see
below).
It is worth noting that essential agreement of zone measure-
ment readings was lower in routine clinical isolates (91.6%) than
in isolates with known resistant mechanisms (94.8%). The
lowest essential agreement in all tested groups was found in
enterococci with vanA-resistance determinant (87.4%). This
value was substantially lower than that obtained in clinical
isolates (92.3%), which did not include any vancomycin-resis-
tant isolate. This resnlt conld be related to the lower growth
velocity of the former group (personal observation). In addi-
tion, the poor growth of enterococci on Mueller-Hinton agar
has been reported to affect the accuracy of video-assisted
automatic readers [11,12]. Recendy, the lowest correlation of
zone diameters measured manually and using an automatic
image system was also obtained with enterococci [14].
On the other hand, overall agreement for susceptibility
testing interpretation was slighdy higher in routine clinical
isolates (95.5%) than in isolates with a well-characterised resis-
tant mechanism (93.2%). As previously stated, discrepancies
were mainly concentrated in Enterobacteriaceae. Amoxicillin-
clavulanate accounted for the majority of these discrepancies
(0.9% when considering the total number of susceptibility tests
and 16.1% when considering the total number ofdiscrepancies).
The presence of ESBL or IRT enzymes in Enterobacteriaceae
enhanced the variation of measurements with the OSIRIS
system. Table 3 illustrates these variations for different fJ-Iac-
tams. Discrepancies in these isolates were essentially due to the
synergy effect observed in the inhibition zone size measure-
ments in ESBL isolates. The clavulanate contained in the
amoxicillin-clavulanate combination disk enhanced the inhibi-
tion zones of cephalosporins in ESBL-producing isolates (dou-
ble disk synergy test). This approach facilitates the recognition
ofESBL-producing organisms [15] but makes it difficnlt to read
the inhibition zones. In fact, 52.9% of discrepancies in ESLB-
and IRT-producing isolates were due to amoxicillin-clavnlanate
and cephalosporins.
Combining all interpretative resnlts for clinical isolates and
those from isolates with a well-characterised resistant mechan-
ism, 4.1 % minor errors, 1.0% major errors and 2.8% very major
errors were observed. These global resnlts meet the perfor-
mance criteria for susceptibility testing [8,13,16]. However,
considering the more stringent criteria ofNCCLS [9] and FDA
[10] for manufacturers (an acceptable error rate ofless than 1.5%
for very major errors and less than 3% for major errors), resnlts
were not acceptable. Unacceptable errors were observed with
amoxicillin-clavulanate, cefazolin, ceftazidime, gentamicin and
ciprofloxacin in Enterobacteriaceae. However, fJ-Iactam anti-
biotics and Enterobacteriaceae results were acceptable when
globally considered, both in clinical isolates (Table 2) and iso-
lates producing ESBL or IRT enzymes (Table 3). As previously
stated, specific problems were also detected with NFGNRs, and
enterococci, probably due to light and slow growth character-
istics on Muller-Hinton agar media. Interestingly, the OSIRIS
system showed a high performance with MRSA isolates and no
errors were observed with oxacillin. This resnlt could be due to
the apparendy methicillin-homoresistance expressed in our
isolates. This agreement probably wonld decline for those
heteroresistant isolates. In MRSA isolates, a total of 1.6% very
major errors was observed and all were due to ciprofloxacin.
Moreover, 3.1% minor errors were detected, 84% being due to
amikacin. All but one MRSA isolate were resistant to genta-
micin and, phenotypically, the production of the bifunctional
APH(2')-AAC(6') enzyme was inferred. Applying the inter-
pretative reading of the antibiogram criteria [17], isolates
producing this enzyme wonld have been considered to be
resistant to amikacin and all minor errors wonld have disap-
peared. It is also remarkable that a low percentage ofvery major
errors were found in Enterobacteriaceae with ESBL or IRT
enzymes (Table 3). Very major errors (1.4%) were mainly due to
ceftazidime (0.2%) and gentamicin (0.4%). The ceftazidime
value could even be 0% when all ESBL-producing isolates
were considered to be resistant to all cephalosporins, as estab-
lished by the NCCLS for E. coli and K. pneumoniae with these
enzymes [6].
Although we have not evaluated reading times, the OSIRIS
system rapidly reads zone measurements and eliminates tedious
individual antibiotic zone measurements. The time required for
reading 16 antibiotics placed on 120-mm2 plates was less than
3 s, including categorisation of zone diameters as susceptible,
intermediate and resistant. This advantage has been reported
with other video readers, which significandy decrease reading
times [11]. In the OSIRIS system, time taken to provide resnlts
can be longer if the microbiologist decides to check the
diameter inhibition zones in the monitor and to modity the
automatic interpretation resnlts.
In conclusion, our resnlts indicate that the OSIRIS system is
a usefnl tool for the reading and interpretation of inhibition
zone sizes in disk diffusion susceptibility testing. However,
automatic readings need to be slighdy modified to reduce
inhibition zones deviations, which can enhance final perfor-
mance of the OSIRIS system.
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